Veterinary Medicine Information website

Nobivac Respira Bb vet. suspension for injection for dogs

Not authorised
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae

Product identification

Medicine name:
Nobivac Respira Bb vet. suspension for injection for dogs
Active substance:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
    88.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB03
Authorisation status:
  • Surrendered
Authorised in:
  • Cyprus
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
  • CY00825V
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0123/002

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 29/05/2023

PI.pdf

English (PDF)
Published on: 27/01/2022
Download